| 王玉萍.经皮内镜下胃/空肠造口置管术在重症急性胰腺炎患者中的临床观察王玉萍 杜爱卿 郑卫娟 浙江金华广福医院营养科 321000[J].浙江中西医结合杂志,2016,26(2): |
| 经皮内镜下胃/空肠造口置管术在重症急性胰腺炎患者中的临床观察王玉萍 杜爱卿 郑卫娟 浙江金华广福医院营养科 321000 |
| Clinical observation of percutaneous endoscopic stomach / Jejunum Stoma tube in severe acute pancreatitis |
| 投稿时间：2015-05-25 修订日期：2015-07-25 |
| DOI： |
| 中文关键词: 经皮内镜下胃/空肠造口置管术 重症急性胰腺炎 营养支持 安全性 |
| 英文关键词:percutaneous endoscopic gastric / Jejunum Stoma catheterization, severe acute pancreatitis(SAP), nutritional support, safety |
| 基金项目: |
|
| 摘要点击次数: 1085 |
| 全文下载次数: 7 |
| 中文摘要: |
| 目的 观察经皮内镜下胃/空肠造口置管术在重症急性胰腺炎患者的营养支持方面的疗效。方法 纳入重症急性胰腺炎患者70例,随机分为治疗组(30例)和对照组(30例),采用不同的肠内营养方式进行治疗。于治疗前和治疗14天时,测量上臂肌围,并采集外周静脉血检测血清白蛋白、血红蛋白和血清淀粉酶水平,同时观察治疗过程中的并发症情况,统计患者住院天数和总费用等情况,从而对两种肠内营养方式进行疗效评估。结果 治疗后,两组患者AMC、AMS水平降低(P<0.05,P<0.01),ALB、Hb水平升高(P<0.05,P<0.01),治疗前后组间差异均无统计学意义(P＞0.05)。治疗组在住院天数以及总费用方面明显少于对照组(P<0.05,P<0.01)。不良反应发生率方面,治疗组为15.38%,对照组为40%,组间差异有统计学意义(P＜0.05)。结论 经皮内镜下胃/空肠造口置管术能缩短患者住院天数,减少治疗费用和术中并发症发生率,其安全性高于常规肠内营养疗法。 |
| 英文摘要: |
| Objective To observe the effect of percutaneous endoscopic stomach / Jejunum Stoma tube in the nutrition support for patients with severe acute pancreatitis. Methods Included 70 patients with severe acute pancreatitis, and they were randomly divided into the treatment group (30 cases) and the control group (30 cases), by using different enteral nutrition treatment. Before and treatment for 14 days, we measured the arm muscle circumference(AMC), and collected peripheral vein blood to detect the level of serum albumin(ALB), hemoglobin Blood(HGB) and amylase(AMS), while observing complications in the different treatments, evaluating the hospitalization days and total cost of the treatment, in order to evaluate the different enteral nutrition methods. Results After the treatments, the level of AMC and AMS were decreased (P<0.05, P<0.01), while ., Hb, the level of ALB and HGB were increased (P<0.05, P<0.01) in both two groups, and there was no significant difference between the two groups (P > 0.05) around the treatment. The number of hospitalization days and total cost in the treatment group was significantly less than that of the control group’s (P<0.01, P<0.05). In the incidence of adverse reactions, the treatment group was 15.38%, while the control group was 40%, and there was no statistically significant between the two groups (P < 0.05). |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
